Clinical Research Directory
Browse clinical research sites, groups, and studies.
BCAAs in Concussion 3.0
Sponsor: Akiva Cohen
Summary
This study is a randomized, placebo-controlled, double-blinded, therapeutic exploratory clinical trial of branched chain amino acids (BCAAs) in the treatment of concussion. The aim of the study is to determine whether administration of high-dose BCAAs compared to placebo promotes concussion recovery.
Official title: HIT HEADS 3.0: Head Injury Treatment: A Randomized, Placebo-controlled, Double-blinded, Therapeutic Clinical Trial of Branched Chain Amino Acids (BCAAs) in the Treatment of Concussion
Key Details
Gender
All
Age Range
11 Years - 23 Years
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2026-07
Completion Date
2027-12
Last Updated
2026-06-26
Healthy Volunteers
Yes
Interventions
BCAA
The three BCAAs will be combined together into a powder formulation.
Placebo
The placebo formulation will have similar taste, texture, consistency and appearance as the BCAA formulation.